In a head-to-head comparison, tirzepatide (first approved in 2022) has indeed performed better than semaglutide at treating obesity
WHAT IS OXIDATIVE STRESS
Without that data, BPC-157 remains a research-only peptide that cannot be prescribed, marketed, or recommended for GERD or acid reflux treatment despite compelling preclinical evidence
Its safe to say, with such a significant percentage of the population affected by this disease, that any medical solution that could alleviate the ongoing insulin shortage would be ideal
Why This Matters More for Midlife Women Midlife women are arguably the population microdosing was accidentally invented for, and the argument rests on three pieces of biology
These treatments help regulate appetite, reduce cravings, improve insulin sensitivity, and support healthier energy balance for long-term results